As seasonal flu season approaches, health care professionals who care for pediatric populations require updated information on the epidemiology, diagnosis, management, and prevention of influenza. This information will not only better prepare clinicians for seasonal influenza but will also aid influenza pandemic preparedness in the event of an outbreak. This program provides information from experts in the field of influenza for clinicians who are actively managing pediatric populations.

Pediatricians and affiliated health care professionals involved in the care of children at risk for seasonal and pandemic influenza.

• Identify strategies for evaluating pediatric patients at risk for influenza, based on current diagnostics and epidemiologic data
• Utilize knowledge of current treatment guidelines and expert recommendations to prepare for appropriate use of antiviral therapies for the treatment of influenza in children
• Implement clinical practices that adhere to expert-recommended influenza prevention and management measures in pediatric patients, as noted in current guidelines

Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the NYU Post-Graduate Medical School and Lenox Hill Hospital. The NYU Post-Graduate Medical School is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement
The NYU Post-Graduate Medical School designates this educational activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should only claim credits commensurate with the extent of their participation in the activity.

For further information about this internet CME activity, contact the NYU Post-Graduate Medical School at 212-263-5292.

The NYU Post-Graduate Medical School adheres to ACCME Essential Areas and Policies, including the Standards for Commercial Support regarding industry support of continuing medical education. In order to resolve any identified conflicts of interest, disclosure information is provided during the planning process to ensure resolution of any identified conflicts. Disclosure of faculty and commercial relationships, as well as the discussion of unlabeled or unapproved use of any drug, device, or procedure by the faculty, is made known below.

John S. Bradley, is contracted to manage clinical trials for MedImmune.

David W. Kimberlin, MD, has no real or apparent conflicts of interest to report.

Andrew T. Pavia, MD, is a consultant for Boehringer Ingelheim and Pfizer.

Richard J. Whitley, MD, is a consultant for Gilead Sciences.

The independent CME reviewer of this activity has no real or apparent conflicts of interest to report.

Internet Activity

Windows

• Windows 2000, ME, XP, Vista
• IE 5.0 or later/Netscape 7/Mozilla 1.5/Opera 7/Firefox
• Flash 7 or later

Macintosh

• OS X
• Safari/Mozilla 1.5/Firefox
• Flash 7 or later

Internet Connection

• Minimum connection of 56Kbps

For further information about the NYU School of Medicine privacy and confidentiality policy, click here: http://www.med.nyu.edu/contact/privacy.html

Unless otherwise noted, all documents accessed from this page are viewed as a precious resource of NYU and are copyright, NYU Post-Graduate Medical School, all rights reserved.